Connect & Inspire

Share Your Story

Explore & Discover

Treatment & Care

Press Room

Subscribe

Meet Fernanda Arnaldez, MD, One of OSI’s Newest Strategic Advisory Board Members

With more than 20 years of expertise studying rare diseases, Dr. Arnaldez is working to remove barriers to developing osteosarcoma treatments.

LATEST POSTS

Connect & Inspire

Stories of inspiration, community, and survival 

A Triathlete Leaves Cancer in His Tracks

A Triathlete Leaves Cancer in His Tracks

Evan’s “personal best” meant beating osteosarcoma, which gave him the willpower to take on new challenges.
Read More
Eva’s Intuition About Cancer Helped Save Her Life

Eva’s Intuition About Cancer Helped Save Her Life

Multiple doctors assured her nothing was wrong, but Eva sensed something wasn’t right in her body. Here, she shares her osteosarcoma journey and how she made it through.
Read More
A Life With Osteosarcoma but Without Limits

A Life With Osteosarcoma but Without Limits

Osteosarcoma survivor and five-time Paralympian carries the torch for disabled athletes and cancer survivors alike.
Read More
View More

Share Your Story

Fill out the form below to tell us about yourself. Sharing stories of osteosarcoma families helps us raise awareness and funds for much-needed research.

Share My Story

Gavin, Osteosarcoma Patient 

Explore & Discover

Stories of research, progress and exploration

The Osteosarcoma Institute’s Year in Review

OSI Director Lee Helman, MD, looks at where we started, where we are, and where we’re going.
Read More

Meet OSI’s New Scientific Project Manager

OSI is thrilled to welcome Amy Lobner, MPH, CCRC, who brings with her a vast skill set rooted in clinical research and scientific development.
Read More
Meet Fernanda Arnaldez, MD, One of OSI’s Newest Strategic Advisory Board Members

Meet Fernanda Arnaldez, MD, One of OSI’s Newest Strategic Advisory Board Members

With more than 20 years of expertise studying rare diseases, Dr. Arnaldez is working to remove barriers to developing osteosarcoma treatments.
Read More
View More

Treatment and Care

A Paradigm Shift That May Change the Way Osteosarcoma is Treated

A Paradigm Shift That May Change the Way Osteosarcoma is Treated

General Info, Treatment and Care
Pediatric oncologist and researcher, Richard Gorlick, MD, is on a mission to improve osteosarcoma outcomes.
Read More
OSI’s Director Unveils 2021’s Grant Recipients

OSI’s Director Unveils 2021’s Grant Recipients

Feature, General Info, Treatment and Care
After receiving a record 26 proposals, Lee Helman, MD, shares the three winning projects the institute is funding in its quest improve treatment and, ultimately, eradicate osteosarcoma.
Read More

Press Room

OSI News & updates

North Texas Giving Day Booster: Osteosarcoma Institute

The My Sweet Charity Blog announces the Osteosarcoma Institute's involvement in North Texas Giving Day 2021
Read More

A Phase II clinical trial funded by The Osteosarcoma Institute is now enrolling

This study is being done in order to evaluate the effectiveness of using two drugs (olaparib and ceralasertib) to treat patients with osteosarcoma that has not responded to treatment or has come back after treatment
Read More

Researchers identify surface protein as a new osteosarcoma therapeutic target for antibody-drug conjugates

Novel approach paves the way for vast expansion in the number of drugs targeting osteosarcoma
Read More

Instagram

Before You Go

Sign-up for our newsletter and stay up-to-date about our fight against Osteosarcoma!

Sign Up
Translate »